tiprankstipranks

Greg Zante Insider Profile

4 Followers
Greg Zante, VP, Finance & Administration at Sangamo Biosciences, holds 693.00 shares in Sangamo Biosciences (Ticker: SGMO), holds 149.37K shares in Viking Therapeutics (Ticker: VKTX). Most recently, Greg Zante ― shares of Sangamo Biosciences on ― for an estimated value of ―.
tipranks
Greg Zante

Greg Zante
Sangamo Biosciences (SGMO)
VP, Finance & Administration

Ranked #95,019 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-144.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$8M
99.98%
0.02%
A breakdown of Greg Zante's holdings

Insider Roles

Viking Therapeutics
(VKTX)
CFO
Sangamo Biosciences
(SGMO)
VP, Finance & Administration
Roles that Greg Zante holds in companies

Most Profitable Insider Trade

Stock:
Viking Therapeutics
(VKTX)
Rating:Informative Sell
Date:Jul 31, 2024 - Today
Return:-20.10%
The most profitable trade made by Greg Zante

Greg Zante's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sangamo Biosciences
VP, Finance & Administration
$1.30K
Viking Therapeutics
Oct 28, 2024
CFO
Uninformative Buy
704.28K
$7.86M
List of latest transactions for each holding click on a transaction to see Greg Zante's performance on stock

Greg Zante insider profile FAQ

What is the percentage of profitable transactions made by Greg Zante?
The percentage of profitable transactions made by Greg Zante is 0%.
    What is the average return per transaction made by Greg Zante?
    The average return per transaction made by Greg Zante is -144.30%.
      What stocks does Greg Zante hold?
      Greg Zante holds: SGMO, VKTX stocks.
        What was Greg Zante’s latest transaction?
        Greg Zante latest transaction was an Uninformative Buy of ―.
          What was Greg Zante's most profitable transaction?
          Greg Zante’s most profitable transaction was an Informative Sell of VKTX stock on July 31, 2024. The return on the trade was -20.10%.
            What is Greg Zante's role in Sangamo Biosciences?
            Greg Zante's role in Sangamo Biosciences is VP, Finance & Administration.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.